Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon
- PMID: 3856479
Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon
Abstract
Seven patients with myeloblastic leukemia were treated for 10 days with high-dose (15 or 30 million units/m2/day), human lymphoblastoid interferon (Wellferon) by continuous iv infusion. All patients developed prolonged activated partial thromboplastin time, and four developed prolonged prothrombin time. Factor assays demonstrated low levels of II, VII, IX, X, and XII. Coagulation abnormalities improved after discontinuation of interferon therapy.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical